Nyumbani › Limfoma ya Selu B
Majaribio ya kliniki ya Limfoma ya Selu B yanayovutia washiriki nchini Marekani
Masomo 67 ya Limfoma ya Selu B yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- New York City, NYUtafiti 19
- Houston, TXUtafiti 16
- Chicago, ILUtafiti 12
- Nashville, TNUtafiti 11
- Philadelphia, PAUtafiti 11
- Rochester, MNUtafiti 10
- Baldwin Park, CAUtafiti 9
- Milwaukee, WIUtafiti 9
- Cleveland, OHUtafiti 9
- Salt Lake City, UTUtafiti 8
- Boston, MAUtafiti 8
- Charlotte, NCUtafiti 7
- Pittsburgh, PAUtafiti 7
- Columbus, OHUtafiti 7
- Seattle, WAUtafiti 7
- Washington, DCUtafiti 7
- Dallas, TXUtafiti 7
- Denver, COUtafiti 7
- San Antonio, TXUtafiti 6
- Aurora, COUtafiti 6
- New Haven, CTUtafiti 6
- Edison, NJUtafiti 6
- Atlanta, GAUtafiti 6
- Los Angeles, CAUtafiti 6
- Portland, ORUtafiti 5
- St. Louis, MOUtafiti 5
- Kansas City, MOUtafiti 5
- Mountain View, CAUtafiti 5
- Omaha, NEUtafiti 5
- Ann Arbor, MIUtafiti 5
- Tampa, FLUtafiti 4
- Jacksonville, FLUtafiti 4
- Richmond, VAUtafiti 4
- Indianapolis, INUtafiti 4
- Winston-Salem, NCUtafiti 4
- Miami, FLUtafiti 4
- Cedar Rapids, IAUtafiti 4
- Cincinnati, OHUtafiti 4
- Louisville, KYUtafiti 4
- Austin, TXUtafiti 3
Kwa jimbo
- ArizonaUtafiti 5
- CaliforniaUtafiti 20
- ColoradoUtafiti 11
- ConnecticutUtafiti 6
- FloridaUtafiti 15
- GeorgiaUtafiti 8
- IllinoisUtafiti 12
- IndianaUtafiti 5
- IowaUtafiti 6
- KansasUtafiti 9
- KentuckyUtafiti 4
- MarylandUtafiti 7
- MassachusettsUtafiti 8
- MichiganUtafiti 7
- MinnesotaUtafiti 12
- MissouriUtafiti 5
- NebraskaUtafiti 5
- New JerseyUtafiti 9
- New YorkUtafiti 21
- North CarolinaUtafiti 11
- OhioUtafiti 17
- OregonUtafiti 6
- PennsylvaniaUtafiti 16
- TennesseeUtafiti 13
- TexasUtafiti 26
- UtahUtafiti 8
- VirginiaUtafiti 8
- WashingtonUtafiti 10
- Wilaya ya ColumbiaUtafiti 3
- WisconsinUtafiti 10
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06343311Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
InaajiriUtafiti wa uchunguzi
Umri 0 hadi 38 · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06131801CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
InaajiriHatua 1/2
Umri 3 hadi 39 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT05442515A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06742996A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07439653Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06350318Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
InaajiriHatua 2
Umri 60 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06052826A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06213311A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07101328A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT05615636A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
InaajiriHatua 1
Umri 0 hadi 18 · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT06173518UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
InaajiriHatua 1/2
31 Days – 30 Years · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT04544592Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT06526793A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT06634589Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT05272384Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT07225439A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT06564038A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Sep 2026 · NCT06393738Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
InaajiriUtafiti wa uchunguzi
Umri 4 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07652580Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 31 Ago 2026 · NCT07516093A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT07123454Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT07520006A Study of ARC-02 in B-cell NHL
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 26 Ago 2026 · NCT07691606Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
InaajiriHatua 1
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT05389423Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT05826535Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.